The main objective of this application is to determine epithelial-stromal interactions, which increase local estrogen biosynthesis and inhibit adipocyte differentiation in malignant breast tumors. We hypothesize that malignant epithelial cells inhibit the differentiation of surrounding adipose fibroblasts to mature adipocytes. This results in the formation of a dense fibroblastic layer around epithelial cells. These fibroblasts provide structural and estrogenic support to epithelial cells. Epithelial factors also upregulate aromatase expression in these undifferentiated fibroblasts by activating aberrant promoter regions of the CYP19 (aromatase) gene. Our preliminary data are as following: (i) Expression of aromatase, the rate-limiting enzyme in estrogen biosynthesis, is regulated by multiple cell-specific promoters distributed within the 90-kb 5'-flanking region of the CYP19 gene via alternative splicing. (ii) Malignant epithelial cells secrete factors that aberrantly activate promoter II in adjacent adipose tissue fibroblasts. This increases the tissue levels of aromatase mRNA originating from promoter II but containing an identical coding region and thus giving rise to an identical functional protein regardless of the promoter use. (iii) The switch from the physiological adipose tissue promoter (I.4) to the pathologically used cancer tissue promoter (II) in adipose fibroblasts is regulated by differential binding of coactivator or corepressor complexes to these regions in a reciprocal fashion. (iv) In response to estrogen, malignant epithelial cells secrete large quantities of TNF and IL-11 that inhibit the differentiation of adipose fibroblasts to mature adipocytes, and thus, increase the number of aromatase-expressing fibroblasts adjacent to malignant cells. (v) We recently cloned a novel promoter region of the CYP19 (aromatase) gene, which is upregulated in breast cancer tissue compared with breast fat distal to cancer. In order to define molecular and cellular mechanisms responsible for aromatase overexpression and inhibition of adipocyte differentiation in breast cancer tissue, we are proposing the following aims: 1) to characterize paracrine and autocrine mechanisms responsible for estrogen-mediated upregulation of TNF, IL-11 and their receptors in breast tumor tissue; 2) to identify common transcriptional enhancers and associated signaling pathways that activate the CYP19 gene and other estrogenic genes in adipose tissue fibroblasts in response to malignant epithelial cell-derived factors; 3) to determine the cell-specific distribution of a novel CYP19 (aromatase) gene promoter and its biological roles in breast cancer and disease-free tissues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA067167-08
Application #
6699951
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Sathyamoorthy, Neeraja
Project Start
1996-05-03
Project End
2006-11-30
Budget Start
2004-03-18
Budget End
2004-11-30
Support Year
8
Fiscal Year
2004
Total Cost
$297,371
Indirect Cost
Name
Northwestern University at Chicago
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Moy, I; Todorovi?, V; Dubash, A D et al. (2015) Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells. Oncogene 34:323-33
Zhao, Hong; Pearson, Elizabeth K; Brooks, David C et al. (2012) A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice. Endocrinology 153:2701-13
Chen, Dong; Zhao, Hong; Coon 5th, John S et al. (2012) Weight gain increases human aromatase expression in mammary gland. Mol Cell Endocrinol 355:114-20
Bulun, Serdar E; Chen, Dong; Moy, Irene et al. (2012) Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab 23:83-9
Chen, Dong; Reierstad, Scott; Fang, Feng et al. (2011) JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters. Mol Endocrinol 25:767-75
Demura, Masashi; Demura, Yoshiki; Ameshima, Shingo et al. (2011) Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer. Lung Cancer 73:289-93
Lin, Z; Yin, P; Reierstad, S et al. (2010) Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer. Oncogene 29:1114-22
Zhao, Hong; Innes, Joy; Brooks, David C et al. (2009) A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue. Reprod Biol Endocrinol 7:37
Bulun, S E; Lin, Z; Zhao, H et al. (2009) Regulation of aromatase expression in breast cancer tissue. Ann N Y Acad Sci 1155:121-31
Bulun, Serdar E; Chen, Dong; Lu, Meiling et al. (2007) Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol 106:81-96

Showing the most recent 10 out of 11 publications